Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
AtaiBeckley will host a Virtual Investor Day on Friday, March 6, 2026, from 9:00 a.m. to 12:00 p.m. ET.
-
AtaiBeckley today announced the appointment of Michael Faerm as Chief Financial Officer, effective March 9, 2026.
-
Srinivas Rao, Co-Founder and Chief Executive Officer, and Jason Awe, VP of Investor Relations, will participate in several investor conferences.
-
AtaiBeckley announced participation in the 64th Annual Meeting of the American College of Neuropsychopharmacology (ACNP)
-
AtaiBeckley provides its outlook for 2026 ahead of attendance at the J.P. Morgan 44th Annual Healthcare Conference
-
NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by...
-
NEW YORK and AMSTERDAM, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Atai Beckley N.V. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biopharmaceutical company on a mission to transform patient...
-
NEW YORK and AMSTERDAM, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Atai Beckley N.V. (NASDAQ: ATAI) (“AtaiBeckley” or the “Company”), a clinical-stage biopharmaceutical company on a mission to transform...